Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of Obatoclax Mesylate (GX15-070MS) for treating Myelodysplastic Syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Obatoclax Mesylate (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED